LIST OF PATENTS. Patent Number Author ------------- ------ [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] THE SYMBOL [***] IS USED TO INDICATE THAT A PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. CONFIDENTIAL TREATMENT REQUESTED Schedule 18.11 PAYMENTS INVOICED TO MATRIA DESCRIPTION INVOICE # $ AMOUNT ----------- --------- -------- Lab Tests 22836 $ 19,065.00 fFN Complete Kit 22906 $ 14,850.00* Lab Tests 22982 $ 17,763.00 Lab Tests 22942 $ 20,584.00 TOTAL OUTSTANDING $ 72,262.00 *INVOICE 22906 = $29,850 LESS PAYMENT $15,000 RECEIVED PAYMENTS INVOICED TO ADEZA DESCRIPTION INVOICE DATE $ AMOUNT ----------- ------------ -------- FedEx Charges December $ 15,446.52 FedEx Charges January $ 13,247.21 FedEx Charges February $ 16,844.73 TOTAL OUTSTANDING $ 45,538.46 THE SYMBOL [***] IS USED TO INDICATE THAT A PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTION. CONFIDENTIAL TREATMENT REQUESTED EXHIBIT A TRANSITION RESPONSIBILITIES Matria Responsibilities Matria shall, during the Transition Period, perform in good faith the following responsibilities with respect to the fFN ELISA Tests and the fFN Rapid Assay Tests, in substantially the same manner and with the same degree of care that it performed such responsibilities during the ninety (90) day period preceding the Effective Date. Matria shall process and fill orders for fFN ELISA Tests and provide customer service and support. Matria shall pay for the fFN ELISA Tests distributed by Matria during the Transition Period in accordance with the payment practices in effect during the ninety (90) day period preceding the Effective Date, except that (i) the price that Matria will pay for the ELISA kits purchased during the Transition Period shall be $[***], (ii) the price per fFN ELISA Test shall be $[***] plus [***]% of all reimbursement amounts in excess of $[***] collected by Matria for such test and (iii) Adeza shall provide to Matria, at Adeza's expense, [***] individual specimen collection kits for each fFN ELISA Test sold to Matria or [***] individual specimen collection kits, whichever is greater. In the event that Matria requires more than [***] individual specimen collection kit...
LIST OF PATENTS. No. Description patent Owned or Co- Owned by AMT reference No Date of filing provisional application Patent number [Other] Strategic Partnerships/Licenses LIST OF PATENTS No. Description patent Owned or Co- Owned by AMT reference No Date of filing provisional application Patent number [Other] LIST OF PATENTS No. Description patent Owned or Co- Owned by AMT reference No Date of filing provisional application Patent number [Other]
LIST OF PATENTS. The parties agree to substitute an English translation for Exhibit A prior to the closing, such list to include not less than all patents described in Exhibit B hereto.
LIST OF PATENTS. (Patent Applications, Patents, and Legal Equivalents Thereto)
LIST OF PATENTS. Pursuant to Section 9.6.1 of the Agreement, the following Patents that cover the Process are [**] [**] Country/Treaty Patent/Application # Title Filing Date [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] Country/Treaty Patent/Application # Title Filing Date [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**]
LIST OF PATENTS. Patterned Non-woven Fabrics of 5,380,581 1/14/2014 Improved Tensile Strength Wear Resistant Image Printing 5,854,306 1/5/2016 on Latex Surfaces Gloves with Reinforcing Elements 11/934495 11/2/2007 (Reinforced Cell) (pending application) Glove Dispenser D530,224 10/17/2020 Glove D515,782 2/28/2020 Glove D515,783 2/28/2020 Glove D515,784 2/28/2020 Glove D513,655 1/24/2020 Glove D516,277 3/7/2020 Multilayer Glove D528,264 9/19/2020 Glove Clip D523,330 6/20/2020 Glove D428,214 7/11/2014 None. None. None. Not applicable.
LIST OF PATENTS. To RGX’s knowledge, Appendix A sets forth a complete list of all Patents and Patent applications that are owned, controlled by or licensed to RGX as of the Effective Date that are necessary or useful for the rights, licenses and sublicenses to the RGX Technology granted to QLT hereunder; (g) Patent Applications Valid and Accurate. To RGX’s knowledge, the Licensed Patents listed on Appendix A are valid and all statements contained in any applications for the registration of the Licensed Patents were true and correct as of the date of such applications and remain true and correct as of the date of this Agreement. For the purposes hereof, “statements” shall be limited to those statements which, [***] of any claim made under a Licensed Patent; (h)
LIST OF PATENTS. (Patent Applications, Patents, and Legal Equivalents Thereto) Cell Phone Signal Booster 11/625331 8005513 Dual Cancellation Loop Wireless Repeater 12/106468 Wireless Repeater Management Systems 12/328076 Dual Loop Active and Passive Repeater Antenna Isolation Improvement 12/425615 5BARz Trademark 78/866260 Multi-Band Wireless Repeater 12/235313 + Foreign filings 8027636 Antenna Docking Station 12/625347 Turning Weak Spots Into Sweet Spots Trademark 78-938374 MARKS: 5BARz™ Turning Weak Spots into Sweet Spots™ This Revolving Line of Credit Agreement (the “Agreement” or the “LOC Agreement”) is made and entered into this 5th day of October, 2010 (the “Effective Date”), and amended and restated this 26th day of March, 2012, by and among 5BARz International Inc., a Nevada corporation (the “Lender”), and CelLynx Group, Inc., a Nevada corporation (“Borrower”). In consideration of the mutual covenants and agreements contained herein, the parties agree as follows:
LIST OF PATENTS. Power Spectra Patents PSI has obtained a number of patents to protect its intellectual property rights. PSI currently holds five (5) patents on its BASS(TM) devices. Current BASS patents are:
